Exelixis (NASDAQ: EXEL) reported Q3 EPS of $0.10, $0.05 worse than the analyst estimate of $0.15. Revenue for the quarter came in at $471.92 million versus the consensus estimate of $471.64 million.

For earnings history and earnings-related data on Exelixis (EXEL) click here.